Document:

Exhibit 10.8

 

CONSULTING
AGREEMENT

 

THIS
CONSULTING AGREEMENT (this “Agreement”) is made and entered into effective as of February 16, 2018 (the
“Effective Date”), by and among Dandrit Biotech USA, Inc. (the “Company”), its wholly owned
subsidiary, Enochian Biopharma, Inc. (“Enochian”) and Weird Science LLC, a California limited liability company
(the “Consultant”).

 

WHEREAS,
on the Effective Date, the parties desire to enter into this Agreement pursuant to which the Consultant will provide the Consulting
Services (as defined herein).

 

NOW,
THEREFORE, in consideration of the mutual promises, covenants and promises contained herein, and intending to be legally bound
hereby, the Company and the Consultant do hereby agree and covenant as follows:

 

1.            Consulting
Services. The Consultant shall provide the Company and Enochian with the services described on Schedule A attached
hereto (the “Consulting Services”).

 

2.            Payment;
Reimbursements.

 

(a)          Consultant
shall be compensated according to the “Schedule of Compensation” set forth on Schedule B attached hereto.

 

(b)          All
normal and customary business expenses incurred by the Consultant under this Agreement shall be paid by the Consultant, and reimbursed
by the Company or paid by the Company upon the request of the Consultant; provided, however, that the Consultant shall not receive
reimbursements for business expenses in excess of $50.00 without prior written approval of the Company.

 

3.            Independent
Contractor Relationship. All services rendered hereunder by the Consultant shall be as an independent contractor. Any persons
employed by the Consultant shall be deemed conclusively as employees of the Consultant, and they shall at all times be under the
Consultant’s direction and control, and they shall be bound to the same terms as Consultant under this Agreement and under
that certain Non-Disclosure and Confidentiality Agreement between the Company and Consultant dated of even date herewith (the
“Non-Disclosure and Confidentiality Agreement”). The Consultant shall have the full power, authority, and discretion
to select the means, manner, and method of performing the services hereunder without detail, control or direction from the Company
or its officers or directors. Neither the Consultant, nor its manager, members or any individual employed by the Consultant shall
be considered employees of the Company or Enochian for any purposes and they shall not be entitled to participate in any employee
benefit plans sponsored or maintained by the Company.

 

4.            Term;
Termination; Future Services.

 

(a)          The
Consultant shall commence providing services on the Effective Date, and shall continue to do so until the date this Agreement
is terminated in accordance with Section 4(b) below (the “Termination Date”).

 

    1

     

    

 

(b)          This
Agreement is terminable at any time by either party upon three (3) months prior written notice to the other party, effective as
of the date set forth in such notice; provided that Company may terminate Consultant immediately for “cause”, which
shall mean any manager, member or employee of Consultant’s (i) indictment for, conviction of or pleading of guilty or nolo
contendere to, a felony or any crime involving moral turpitude; (ii) violation of any an order, sentence, plea or settlement
agreement or adjudication (each, an “Order”) of a court competent jurisdiction, including such Orders existing
as of the Effective Date; (iii) breach of any obligations of confidentiality provided herein or any unauthorized disclosure of
any Company trade secrets or other confidential information; (iv) performance of any material act of theft, embezzlement, fraud,
malfeasance, dishonesty or misappropriation of the Company’s property; or (v) material breach of this Agreement or any other
material agreement with the Company or a material violation of the Company’s code of conduct or other written policy; provided
further that any “cause” shall only apply to an occurrence after the Effective Date. Sections 3, 7, 8, 9, 10, 11,
13 and 15 shall survive termination of this Agreement for any reason. For purposes of this Agreement, email notification shall
be deemed to be written notice.

 

(c)          For
the avoidance of doubt, any services performed by the Consultant for the Company or Enochian following the Termination Date shall
not be deemed as Consulting Services governed by this Agreement.

 

5.            Consultant
Responsible for Taxes. The Consultant agrees to accept exclusive liability for the payment of taxes due on any amounts paid
under this Agreement.

 

6.            Non-Disclosure
and Confidentiality Agreement. The Consultant agrees to continue to be bound by the Non-Disclosure and Confidentiality Agreement.

 

7.            Ownership.

 

(a)          All
information, technology, ideas, concepts, improvements, discoveries and inventions, whether patentable or not, which are conceived,
made, developed, discovered, or acquired and/or reduced to practice by Consultant, solely or in combination with others, or which
are disclosed or made known to Consultant, individually or in combination with others, during the Term and which are related to
the Company’s and/or Enochian’s business, technology, intellectual property, products, processes, procedures and/
or services, and/or that Consultant has been or may be directed to undertake, investigate or experiment with by or for the Company
and/or Enochian and/or that Consultant has or may become associated with in work, investigation or experimentation by or for the
Company and/or Enochian in performing the services under this Agreement or in contemplation hereof (including all such information
relating to corporate opportunities, research, development, marketing, processing, financial and sales data, pricing and trading
terms, evaluations, opinions, interpretations, acquisition prospects, the identity of clients or customers or their requirements,
the identity of key contacts within the client or customers’ organizations or within the organization of acquisition prospects,
or marketing and merchandising techniques, prospective names and marks) (collectively, “Inventions”) are and shall
be the sole and exclusive property of the Company and/or Enochian, as limited to HIV as set forth in Section 7(g). Moreover, all
drawings, memoranda, notes, records, files, correspondence, manuals, models, specifications, computer programs, maps and all other
writings or materials of any type embodying any of such Inventions, information, ideas, concepts, improvements, discoveries and
inventions are and shall be the sole and exclusive property of the Company and/or Enochian, as limited to HIV as set forth in
Section 7(g). Consultant also agrees to assign (or cause to be assigned) and hereby assigns fully to the Company and/or Enochian
all Inventions and any copyright, patent, trade secret, and mask work rights and/or other intellectual property rights relating
to all Inventions.

 

    2

     

    

 

(b)          In
particular, Consultant hereby specifically assigns and transfers to the Company and/or Enochian all of Consultant’s worldwide
right, title and interest in and to all such Inventions, information, ideas, concepts, improvements, discoveries and/or inventions,
and any United States or foreign applications for patents, inventor’s certificates or other industrial rights that may be
filed thereon, and applications for protection and/or registration of Inventions, such names and/or marks. During the Term and
thereafter, Consultant shall assist the Company and/or Enochian and their nominees at all times in the protection of such Inventions,
information, ideas, concepts, improvements, and/or discoveries or inventions, both in the United States and all foreign countries,
including the execution of all lawful oaths, applications, specifications and all assignment documents and other instruments requested
by the Company and/or Enochian or their nominees in connection with the preparation, prosecution, issuance or enforcement of any
applications for United States or foreign letters patent, and any other document application for the protection and/or registration
of such Inventions, names and/or mark, including the disclosure to the Company and/or Enochian of all pertinent information and
data with respect to all Inventions that the Company and/or Enochian may deem necessary in order to apply for and obtain such
rights and in order to assign and convey to the Company and/or Enochian, their successors, assigns and nominees the sole and exclusive
right, title and interest in and to all Inventions, and any copyright, patent, trade secret, and/or mask work rights or other
intellectual property rights relating to all Inventions. Consultant also agrees that Consultant’s obligation to execute
or cause to be executed any such instrument or papers shall continue after the termination of this Agreement.

 

(c)          Moreover,
if during the Term, Consultant creates any original work of authorship fixed in any tangible medium of expression which is the
subject matter of copyright (such as reports, videotapes, written presentations, computer programs, drawings, maps, architectural
renditions, models, manuals, brochures or the like) related to the Company’s and/or Enochian’s business, technology,
intellectual property, products, processes or services, as limited to HIV as set forth in Section 7(g), whether such work is created
solely by Consultant or jointly with others, the Company and/or Enochian shall be deemed the co-author of such work if the work
is prepared by Consultant in the scope of the Consulting Services hereunder; or, if the work is not prepared by Consultant within
the scope of the Consulting Services hereunder but is specially ordered by the Company and/or Enochian as a contribution to a
collective work, as a part of any written or audiovisual work, as a translation, as a supplementary work, as a compilation or
as an instructional text, then the work shall be considered to be work made for hire and the Company and/or Enochian shall be
the co-author of the work. Both during the Term and thereafter, Consultant shall assist the Company and/or Enochian and their
nominees, at any time, in the protection of the Company’s and/or Enochian’s worldwide right, title and interest in
and to the work and all rights of copyright therein, including the execution of all formal assignment documents requested by the
Company and/or Enochian or their nominees and the execution of all lawful oaths and applications for registration of copyright
in the United States and foreign countries; provided, however, that Consultant shall be compensated by the Company and/or Enochian
at a reasonable hourly rate for assistance given after the end of the Term.

 

    3

     

    

 

(d)          Return
of Company Property. Upon the termination of this Agreement for any reason (or at any time prior thereto at the Company’s
and/or Enochian’s request), Consultant shall return all property belonging to the Company and/or Enochian or their Affiliates
(including any Company and/or Enochian and/or Affiliate-provided laptops, computers, cell phones, wireless electronic mail devices
or other equipment, or materials, information, documents or property, in any form, belonging to the Company and/or Enochian and/or
an Affiliate).

 

(e)
          Pre-Existing Materials. Subject to Section 8(a), Consultant agrees that
if, in the course of performing the Consulting Services, Consultant incorporates into any Invention developed under this Agreement
any pre-existing invention, improvement, development, concept, discovery or other proprietary information owned by Consultant
or in which Consultant has an interest, (i) Consultant will inform Company and/or Enochian, in writing while incorporating such
invention, improvement, development, concept, discovery or other proprietary information into any Invention and (ii) the Company
and/or Enochian and Consultant shall enter into a nonexclusive, perpetual, irrevocable, worldwide license to the Company and/or
Enochian to make, have made, modify, use and sell such item as part of or in connection with such Invention on terms, including
the payment to Consultant of appropriate royalties, which are mutually agreeable by both parties. Consultant will not incorporate
any invention, improvement, development, concept, discovery or other proprietary information owned by any third party into any
Invention without Company’s and/or Enochian’s prior written permission.

 

(f)          Attorney-in-Fact.
Consultant agrees that, if the Company or Enochian is unable because of Consultant’s unavailability, mental or physical
incapacity, or for any other reason, to secure Consultant’s signature for the purpose of applying for or pursuing any application
for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company
or Enochian in Section 8(a), then Consultant hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s behalf to execute and
file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyright
and mask work registrations with the same legal force and effect as if executed by Consultant.

 

(g)
          Inventions limited to HIV Modalities. The Parties acknowledge that the Inventions
and the intellectual property otherwise referred to herein in this Agreement relate only to the intellectual property controlled
by Enochian, namely as applied to the area of HIV research and HIV intellectual property. This Agreement does not otherwise restrict
Consultant from researching, developing, inventing or otherwise pursuing related technology and intellectual property that pertains
to other modalities other than HIV, and Consultant shall have no obligation to Enochian or any other party hereto for inventions
relating to such other modalities. In accordance with the foregoing, Enochian is entering into that certain License Agreement
of equal date hereof, and upon which the Consultant is relying as inducement for entering into this Agreement. Nothing contained
herein is intended to expand Enochian’s rights as set forth in the License Agreement, nor to in any way expand the “Field”
described therein, and Enochian shall not obtain any other rights hereunder greater than its rights within the Field under the
License Agreement. During the term of this Agreement, Enochian will grant the Consultant the nonexclusive, royalty-free, personal
right to assign to any of its members who are medical doctors the right to use the intellectual property controlled by Enochian
relating to HIV treatment in humans solely to treat patients in the personal practice of medicine by such members (the “Right
to Use”).

 

    4

     

    

 

8.           Non-Solicitation.
The Consultant agrees that during the term of this Agreement and for a period of one year after the Termination Date,
the Consultant will not encourage or solicit any employee or consultant of the Company or Enochian to leave the Company or
Enochian for any reason.

 

9.           Arbitration,
Choice of Law. This Agreement shall be deemed to have been executed and delivered within the State of California, and the
rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws
of the State of California without regard to principles of conflict of laws. In the event of a dispute, the parties agree to arbitrate
all claims related to this Agreement before a single arbitrator in Los Angeles County, California under the Rules of the American
Arbitration Association.

 

10.          Severability.
If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other
provisions or applications of the Agreement which can be given effect without the invalid provisions or applications and to
this end, the provisions of this Agreement are declared to be severable.

 

11.          Advice
of Counsel. In entering into this Agreement, the parties recognize that this Agreement is a legally binding contract and acknowledge
and agree that each party has had the opportunity to consult with legal counsel of its choice.

 

12.          Entire
Agreement. This Agreement, the License Agreement, and the Non-Disclosure and Confidentiality Agreement, together with all
schedules and Exhibits made a part hereof and thereof constitute and contain the entire agreement and final understanding between
the parties covering the services to be provided by the Consultant. It is intended by the parties as a complete and exclusive
statement of the terms of their agreement, and they supersede all prior negotiations and agreements, proposed or otherwise, whether
written or oral, between the parties concerning Consulting Services. Any representation, promise or agreement not specifically
included in this Agreement shall not be binding upon or enforceable against either party. This Agreement may be modified only
with a written instrument duly executed by each of the parties. No person has any authority to make any representation or promise
on behalf of any of the parties not set forth herein and this Agreement has not been executed in reliance upon any representations
or promises except those contained herein.

 

13.          No
Assignment. The Consultant shall not assign either in whole or in part any of the Consultant’s duties or responsibilities
hereunder without the written consent of the Company, and any attempt of assignment transfer or delegation without such consent
shall be void.

 

14.          Written
Reports. The Consultant, when directed, shall provide written reports to Company’s Chief Executive Officer with respect
to the services rendered hereunder.

 

15.          Headings.
Headings are used only for ease of reference and are not controlling.

 

    5

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date first above written.

 

DANDRIT
BIOTECH USA, INC.:

 

	By	/s/ Eric Leire
	Name: Dr. Eric Leire
	Title: Chief Executive Officer

 

Notice
Address:

 

Stumpedyssevej
17

2970
Hørsholm, Denmark

 

Email:       epl@dandrit.com

With
a copy to:    

clayton.parker@klgates.com

 

ENOCHIAN
BIOPHARMA, INC.:

 

	By	/s/ Eric Leire
	Name: Dr. Eric Leire
	Title: Chief Executive Officer

 

Stumpedyssevej
17

2970
Hørsholm, Denmark

 

Email:        epl@dandrit.com

With
a copy to:    

clayton.parker@klgates.com

CONSULTANT:

 

	/s/ Carl Sandler
	Name: Carl Sandler
	Title: Manager

 

Notice
Address:

 

330
East 33rd Street, 3A

New
York, NY 10016

 

Email:       carlforest@gmail.com

With
a copy to: 

andersonwittekind@gmail.com

 

SIGNATURE PAGE TO CONSULTING AGREEMENTExhibit 10.9

 

EXECUTION VERSION

 

CONSULTING AGREEMENT

 

This CONSULTING
AGREEMENT (this “Agreement”) is made and entered into as of February 16, 2018 (the “Effective Date”),
by and among Dandrit Biotech USA, Inc. (the “Company”), its wholly owned subsidiary, Enochian Biopharma, Inc.
(“Enochian) and Carl Sandler, an individual (the “Consultant”).

 

WHEREAS, on
the Effective Date, the parties desire to enter into this Agreement pursuant to which the Consultant will provide the Consulting
Services (as defined herein).

 

NOW, THEREFORE,
in consideration of the mutual promises, covenants and agreements contained herein, and intending to be legally bound hereby, the
Company and the Consultant do hereby agree and covenant as follows:

 

1.            Consulting
Services. The Consultant shall provide the Company and Enochian with the services described on Schedule A attached hereto
(the “Consulting Services”).

 

2.            Payment;
Reimbursements.

 

(a)          Consultant
shall be compensated $10,000 monthly, in accordance with the Company’s then current payroll practices.

 

(b)          All
normal and customary business expenses incurred by the Consultant under this Agreement shall be paid by the Consultant, and reimbursed
by the Company or paid by the Company upon the request of the Consultant; provided, however, that the Consultant shall not receive
reimbursements for business expenses in excess of $50.00 without prior written approval of the Company.

 

3.            Independent
Contractor Relationship. All services rendered hereunder by the Consultant shall as an independent contractor. Any persons
employed by the Consultant shall be deemed conclusively as employees of the Consultant, and they shall at all times be under the
Consultant’s direction and control, and they shall be bound to the same terms as Consultant under this Agreement and under
that certain Non-Disclosure and Confidentiality Agreement between the Company and Consultant of even date herewith (the “Non-Disclosure
and Confidentiality Agreement”).1
The Consultant shall have the full power, authority, and discretion to select the means, manner, and method of performing the services
hereunder without detail, control or direction from the Company or its officers or directors. Neither the Consultant nor any individuals
employed by the Consultant shall be considered employees of the Company or Enochian for any purposes and they shall not be entitled
to participate in any employee benefit plans sponsored or maintained by the Company.

 

 

1
NTD: DanDrit to provide requested form of NDA.

 

    1

     

    

 

4.            Term;
Termination; Future Services.

 

(a)          The
Consultant shall commence providing services on the Effective Date and shall continue to do so for six (6) months, or earlier in
the event this Agreement is terminated in accordance with Section 4(b) below (the “Termination Date”).

 

(b)          This
Agreement is terminable at any time by either party upon one (1) month prior written notice to the other party, effective as of
the date set forth in such notice; provided that Company may terminate Consultant immediately for cause, which shall mean Consultant’s
(i) indictment for, conviction of or pleading of guilty or nolo contendere to, a felony or any crime involving moral turpitude;
(ii) breach of any obligations of confidentiality provided herein or any unauthorized disclosure of any Company trade secrets
or other confidential information; (iii) performance of any material act of theft, embezzlement, fraud, malfeasance, dishonesty
or misappropriation of the Company’s property; or (iv) material breach of this Agreement or any other material agreement
with the Company or a material violation of the Company’s code of conduct or other written policy; provided further that,
Sections 3, 7, 8, 9, 10, 11, 13 and 15 shall survive termination of this Agreement for any reason. For purposes of this Agreement,
email notification shall be deemed to be written notice.

 

(c)          For
the avoidance of doubt, any services performed by the Consultant for the Company or Enochian following the Termination Date shall
not be deemed as Consulting Services governed by this Agreement.

 

5.            Conflict
of Interest. During the term of this Agreement, the Consultant must promptly disclose in writing to the Company any actual
or potential conflict that the Consultant may have in performing the Consulting Services hereunder; provided, however, that it
is acknowledged and understood by the parties that following the Effective Date the Consultant will continue to hold an equity
interest in, be a Manager of and perform certain services for Weird Science LLC.

 

6.            Consultant
Responsible for Taxes. The Consultant agrees to accept exclusive liability for the payment of taxes due on any amounts paid
under this Agreement.

 

7.            Non-Disclosure
and Confidentiality Agreement. The Consultant agrees to continue to be bound by the Non-Disclosure and Confidentiality Agreement.

 

8.            Ownership.

 

(a)          All
information, technology, ideas, concepts, improvements, discoveries and inventions, whether patentable or not, which are conceived,
made, developed, discovered, or acquired and/or reduced to practice by Consultant, solely or in combination with others, or which
are disclosed or made known to Consultant, individually or in combination with others, during the Term and which are related to
the Company’s and/or Enochian’s business, technology, intellectual property, products, processes, procedures and/ or
services, and/or that Consultant has been or may be directed to undertake, investigate or experiment with by or for the Company
and/or Enochian and/or that Consultant has or may become associated with in work, investigation or experimentation by or for the
Company and/or Enochian in performing the services under this Agreement or in contemplation hereof (including all such information
relating to corporate opportunities, research, development, marketing, processing, financial and sales data, pricing and trading
terms, evaluations, opinions, interpretations, acquisition prospects, the identity of clients or customers or their requirements,
the identity of key contacts within the client or customers’ organizations or within the organization of acquisition prospects,
or marketing and merchandising techniques, prospective names and marks) (collectively, “Inventions”) are and shall
be the sole and exclusive property of the Company and/or Enochian as limited to HIV as set forth in Section 8(g). Moreover, all
drawings, memoranda, notes, records, files, correspondence, manuals, models, specifications, computer programs, maps and all other
writings or materials of any type embodying any of such Inventions, information, ideas, concepts, improvements, discoveries and
inventions are and shall be the sole and exclusive property of the Company and/or Enochian as limited to HIV as set forth in Section
8(g). Consultant also agrees to assign (or cause to be assigned) and hereby assigns fully to the Company and/or Enochian all Inventions
and any copyright, patent, trade secret, and mask work rights and/or other intellectual property rights relating to all Inventions.

 

    2

     

    

 

(b)          In
particular, Consultant hereby specifically assigns and transfers to the Company and/or Enochian all of Consultant’s worldwide
right, title and interest in and to all such Inventions, information, ideas, concepts, improvements, discoveries and/or inventions,
and any United States or foreign applications for patents, inventor’s certificates or other industrial rights that may be
filed thereon, and applications for protection and/or registration of Inventions, such names and/or marks. During the Term and
thereafter, Consultant shall assist the Company and/or Enochian and their nominees at all times in the protection of such Inventions,
information, ideas, concepts, improvements, and/or discoveries or inventions, both in the United States and all foreign countries,
including the execution of all lawful oaths, applications, specifications and all assignment documents and other instruments requested
by the Company and/or Enochian or their nominees in connection with the preparation, prosecution, issuance or enforcement of any
applications for United States or foreign letters patent, and any other document application for the protection and/or registration
of such Inventions, names and/or marks, including the disclosure to the Company and/or Enochian of all pertinent information and
data with respect to all Inventions that the Company and/or Enochian may deem necessary in order to apply for and obtain such rights
and in order to assign and convey to the Company and/or Enochian, their successors, assigns and nominees the sole and exclusive
right, title and interest in and to all Inventions, and any copyright, patent, trade secret, and/or mask work rights or other intellectual
property rights relating to all Inventions. Consultant also agrees that Consultant’s obligation to execute or cause to be
executed any such instrument or papers shall continue after the termination of this Agreement.

 

(c)          Moreover,
if during the Term, Consultant creates any original work of authorship fixed in any tangible medium of expression which is the
subject matter of copyright (such as reports, videotapes, written presentations, computer programs, drawings, maps, architectural
renditions, models, manuals, brochures or the like) related to the Company’s and/or Enochian’s business, technology,
intellectual property, products, processes or services, as limited to HIV as set forth in Section 8(g), whether such work is created
solely by Consultant or jointly with others, the Company and/or Enochian shall be deemed the co-author of such work if the work
is prepared by Consultant in the scope of the Consulting Services hereunder; or, if the work is not prepared by Consultant within
the scope of the Consulting Services hereunder but is specially ordered by the Company and/or Enochian as a contribution to a collective
work, as a part of any written or audiovisual work, as a translation, as a supplementary work, as a compilation or as an instructional
text, then the work shall be considered to be work made for hire and the Company and/or Enochian shall be the co-author of the
work. Both during the Term and thereafter, Consultant shall assist the Company and/or Enochian and their nominees, at any time,
in the protection of the Company’s and/or Enochian’s worldwide right, title and interest in and to the work and all
rights of copyright therein, including the execution of all formal assignment documents requested by the Company and/or Enochian
or their nominees and the execution of all lawful oaths and applications for registration of copyright in the United States and
foreign countries; provided, however, that Consultant shall be compensated by the Company and/or Enochian at a reasonable hourly
rate for assistance given after the end of the Term.

 

    3

     

    

 

(d)          Return
of Company Property. Upon the termination of this Agreement for any reason (or at any time prior thereto at the Company’s
and/or Enochian’s request), Consultant shall return all property belonging to the Company and/or Enochian or their Affiliates
(including any the Company and/or Enochian and/or Affiliate-provided laptops, computers, cell phones, wireless electronic mail
devices or other equipment, or materials, information, documents or property, in any form, belonging to the Company and/or Enochian
and/or an Affiliate).

 

(e)          Pre-Existing Materials.
Subject to Section 8(a), Consultant agrees that if, in the course of performing the Consulting Services, Consultant incorporates
into any Invention developed under this Agreement any pre-existing invention, improvement, development, concept, discovery or other
proprietary information owned by Consultant or in which Consultant has an interest, (i) Consultant will inform Company and/or Enochian,
in writing while incorporating such invention, improvement, development, concept, discovery or other proprietary information into
any Invention and (ii) the Company and/or Enochian and Consultant shall enter into a nonexclusive, perpetual, irrevocable, worldwide
license to the Company and/or Enochian to make, have made, modify, use and sell such item as part of or in connection with such
Invention on terms, including the payment to Consultant of appropriate royalties, which are mutually agreeable by both parties.
Consultant will not incorporate any invention, improvement, development, concept, discovery or other proprietary information owned
by any third party into any Invention without Company’s and/or Enochian’s prior written permission.

 

(f)           Attorney-in-Fact.
Consultant agrees that, if the Company or Enochian is unable because of Consultant’s unavailability, mental or physical incapacity,
or for any other reason, to secure Consultant’s signature for the purpose of applying for or pursuing any application for
any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company or
Enochian in Section 8(a), then Consultant hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s behalf to execute and
file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of patents, copyright
and mask work registrations with the same legal force and effect as if executed by Consultant.

 

(g)          Inventions
limited as to HIV Modalities. The Parties acknowledge that the Inventions and the intellectual property otherwise referred
to herein in this Agreement relate to the intellectual property controlled by Enochian, namely as applied to the area of HIV research
and HIV intellectual property. This Agreement does not otherwise restrict Consultant from researching, developing, inventing, or
otherwise pursuing related technology and intellectual property that pertains to other modalities other than HIV, and Consultant
shall have no obligation to Enochian or any other party hereto for inventions relating to such other modalities. In accordance
with the foregoing, Enochian is entering into that certain License Agreement of equal date hereof, and upon which the Consultant
is relying as inducement for entering into this Agreement.

 

    4

     

    

 

9.            Non-Solicitation.
The Consultant agrees that during the term of this Agreement and for a period of one year after the Termination Date, the Consultant
will not encourage or solicit any employee or consultant of the Company or Enochian to leave the Company or Enochian for any reason.

 

10.          Arbitration,
Choice of Law. This Agreement shall be deemed to have been executed and delivered within the State of California, and the rights
and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State
of California without regard to principles of conflict of laws. In the event of a dispute, the parties agree to arbitrate all claims
related to this Agreement before a single arbitrator in Miami-Dade County, Florida under the Rules of the American Arbitration
Association.

 

11.          Severability.
If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions
or applications of the Agreement which can be given effect without the invalid provisions or applications and to this end, the
provisions of this Agreement are declared to be severable.

 

12.          Advice
of Counsel. In entering into this Agreement, the parties recognize that this Agreement is a legally binding contract and acknowledge
and agree that each party has had the opportunity to consult with legal counsel of its choice.

 

13.          Entire
Agreement. This Agreement, the License Agreement, and the Non-Disclosure and Confidentiality Agreement, together with all schedules
and Exhibits made a part hereof and thereof constitute and contain the entire agreement and final understanding between the parties
covering the services to be provided by the Consultant. It is intended by the parties as a complete and exclusive statement of
the terms of their agreement, and they supersede all prior negotiations and agreements, proposed or otherwise, whether written
or oral, between the parties concerning Consulting Services and the Milestones. Any representation, promise or agreement not specifically
included in this Agreement shall not be binding upon or enforceable against either party. This Agreement may be modified only with
a written instrument duly executed by each of the parties. No person has any authority to make any representation or promise on
behalf of any of the parties not set forth herein and this Agreement has not been executed in reliance upon any representations
or promises except those contained herein.

 

14.          No
Assignment. The Consultant shall not assign either in whole or in part any of the Consultant’s duties or responsibilities
hereunder without the written consent of the Company, and any attempt of assignment transfer or delegation without such consent
shall be void.

 

15.          Written
Reports. The Consultant, when directed, shall provide written reports to Company’s Chief Executive Officer with respect
to the Consulting Services rendered hereunder.

 

    5

     

    

 

16.          Headings.
Headings are used only for ease of reference and are not controlling.

 

    6

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.

 

DANDRIT BIOTECH USA, INC.:

 

	By	/s/ Eric Leire
	Name: Dr. Eric Leire
	Title: Chief Executive Officer

 

Notice Address:

 

Stumpedyssevej 17

2970 Hørsholm, Denmark

 

Email:       epl@dandrit.com

With a copy to:     

clayton.parker@klgates.com

 

ENOCHIAN BIOPHARMA, INC.:

 

	By	/s/ Eric Leire
	Name:
	Title: 

 

Notice Address:

5901 W. Olympic Blvd., Suite 419

Los Angeles, CA 90036

 

Email: 

With a copy to:

CONSULTANT:

 

/s/ Carl Sandler

Carl Sandler

 

Notice Address:

 

330 East 33rd Street, 3A

New York, NY 10016

 

Email:   carlforest@gmail.com  

With a copy to:

 

Signature Page to the Consulting Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}]]